A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1

Medicine & Life Sciences

• Tissue Inhibitor of Metalloproteinase-1 100%
• Carcinoembryonic Antigen 94%
• Colorectal Neoplasms 66%
• Serum 37%
• Disease-Free Survival 33%
• Recurrence 27%
• Confidence Intervals 21%
• Neoplasm Metastasis 14%
• Proportional Hazards Models 10%
• Patient Selection 10%
• Risk Assessment 9%
• Multivariate Analysis 8%
• Enzyme-Linked Immunosorbent Assay 8%
• Proteins 4%
• Neoplasms 3%